Our data are consistent with the newly recent reports about LINC00355 acting as an oncogene in other cancers, including bladder cancer, head and neck squamous cell carcinoma, and lung adenocarcinoma43–45. This evidence concerns the gene LINC00355 and urinary bladder cancer.